Altered immunity in migraine: a comprehensive scoping review
- PMID: 38844851
- PMCID: PMC11157828
- DOI: 10.1186/s10194-024-01800-8
Altered immunity in migraine: a comprehensive scoping review
Abstract
Background: The pathogenesis of migraine remains unclear; however, a large body of evidence supports the hypothesis that immunological mechanisms play a key role. Therefore, we aimed to review current studies on altered immunity in individuals with migraine during and outside attacks.
Methods: We searched the PubMed database to investigate immunological changes in patients with migraine. We then added other relevant articles on altered immunity in migraine to our search.
Results: Database screening identified 1,102 articles, of which 41 were selected. We added another 104 relevant articles. We found studies reporting elevated interictal levels of some proinflammatory cytokines, including IL-6 and TNF-α. Anti-inflammatory cytokines showed various findings, such as increased TGF-β and decreased IL-10. Other changes in humoral immunity included increased levels of chemokines, adhesion molecules, and matrix metalloproteinases; activation of the complement system; and increased IgM and IgA. Changes in cellular immunity included an increase in T helper cells, decreased cytotoxic T cells, decreased regulatory T cells, and an increase in a subset of natural killer cells. A significant comorbidity of autoimmune and allergic diseases with migraine was observed.
Conclusions: Our review summarizes the findings regarding altered humoral and cellular immunological findings in human migraine. We highlight the possible involvement of immunological mechanisms in the pathogenesis of migraine. However, further studies are needed to expand our knowledge of the exact role of immunological mechanisms in migraine pathogenesis.
Keywords: Allergy; Autoimmune diseases; Immunity; Inflammation; Lymphocytes; Migraine; Neuroinflammation.
© 2024. The Author(s).
Conflict of interest statement
MKC was the site investigator for a multicenter trial sponsored by Biohaven Pharmaceuticals, Allergan Korea, and the Ildong Pharmaceutical Company. He has received lecture honoraria from Eli Lilly and Company, Handok-Teva, and the Ildong Pharmaceutical Company over the past 24 months. He received grants from the Yonsei University College of Medicine (6-2021-0229), the Korea Health Industry Development Institute (KHIDI) (HV22C0106), and an NRF grant from the Korean government (MSIT) (2022R1A2C1091767). The authors have no conflicts of interest to declare.
Figures


Similar articles
-
Migraine and adiponectin: is there a connection?Cephalalgia. 2007 May;27(5):435-46. doi: 10.1111/j.1468-2982.2007.01306.x. Cephalalgia. 2007. PMID: 17448181 Review.
-
Hypertension: An immune related disorder?Clin Immunol. 2020 Mar;212:108247. doi: 10.1016/j.clim.2019.108247. Epub 2019 Aug 8. Clin Immunol. 2020. PMID: 31401215
-
Evaluation of humoral and cellular immune responses to a DNA vaccine encoding chicken type II collagen for rheumatoid arthritis in normal rats.Hum Vaccin Immunother. 2015;11(4):938-45. doi: 10.1080/21645515.2015.1010977. Hum Vaccin Immunother. 2015. PMID: 25763999 Free PMC article.
-
Comparative analysis of cellular immune responses and cytokine levels in sheep experimentally infected with bluetongue virus serotype 1 and 8.Vet Microbiol. 2015 May 15;177(1-2):95-105. doi: 10.1016/j.vetmic.2015.02.022. Epub 2015 Feb 28. Vet Microbiol. 2015. PMID: 25769647
-
Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines.Eur J Pharmacol. 2019 Feb 5;844:87-94. doi: 10.1016/j.ejphar.2018.12.004. Epub 2018 Dec 6. Eur J Pharmacol. 2019. PMID: 30529470 Review.
Cited by
-
Single-Nucleus Transcriptomics Reveals Glial Metabolic-Immune Rewiring and Intercellular Signaling Disruption in Chronic Migraine.Biomolecules. 2025 Jun 28;15(7):942. doi: 10.3390/biom15070942. Biomolecules. 2025. PMID: 40723814 Free PMC article.
-
Translational Impact of Genetics and Epigenetics of CGRP System on Chronic Migraine Treatment with Onabotulinumtoxin A and Other Biotech Drugs.Toxins (Basel). 2025 Jul 17;17(7):355. doi: 10.3390/toxins17070355. Toxins (Basel). 2025. PMID: 40711166 Free PMC article. Review.
-
Revisiting Migraine Pathophysiology: from Neurons To Immune Cells Through Lens of Immune Regulatory Pathways.J Neuroimmune Pharmacol. 2025 Apr 2;20(1):30. doi: 10.1007/s11481-025-10197-3. J Neuroimmune Pharmacol. 2025. PMID: 40172704 Review.
-
Epidemiological linkage between migraine and diabetes mellitus: a systematic review and meta-analysis.J Headache Pain. 2024 Sep 27;25(1):158. doi: 10.1186/s10194-024-01868-2. J Headache Pain. 2024. PMID: 39333866 Free PMC article.
-
Decoding migraine disorders: parathyroid hormone-related peptide receptors as key genetic drivers.Brain Commun. 2025 Apr 28;7(2):fcaf142. doi: 10.1093/braincomms/fcaf142. eCollection 2025. Brain Commun. 2025. PMID: 40297711 Free PMC article.
References
-
- Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology. 1993;43(6 Suppl 3):S16–20. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous